High-Risk Melanoma: Accuracy of FDG PET/CT with Added CT Morphologic Information for Detection of Metastases
Authors:
- Klaus StrobelKSKlaus Strobel
- Reinhard DummerRDReinhard Dummer
- Daniela B. HusarikDHDaniela B. Husarik
- Marisol Pérez LagoMLMarisol Pérez Lago
- Thomas F. HanyTHThomas F. Hany
- Hans C. SteinertHSHans C. Steinert
- 1 August 2007
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 244 (2) , 566-574
Abstract
Purpose: To prospectively determine the accuracy of positron emission tomography (PET)/computed tomography (CT) with added CT morphologic information for depiction of metastases in patients with high-risk melanoma and negative findings for metastases at PET, by using histologic findings or additional imaging and/or follow-up findings as reference standard. Materials and Methods: Institutional review board approval was obtained. Informed consent was obtained from patients. One hundred twenty-four consecutive high-risk melanoma patients (65 female, 59 male; mean age, 54.4 years; range, 15–82 years) were included. Fluorine 18 fluorodeoxyglucose (FDG) PET/CT was performed. First, PET/CT scans were evaluated for presence of metastases with increased FDG uptake; CT anatomic location was determined. Lesions were considered metastases if there was focal uptake higher than that of background tissue. Second, coregistered CT images of combined PET/CT scans were evaluated for presence of lesions without FDG uptake. F...Keywords
This publication has 27 references indexed in Scilit:
- Baseline staging in cutaneous malignant melanomaBritish Journal of Dermatology, 2004
- The Role of Fluorine-18 Deoxyglucose Positron Emission Tomography in the Management of Patients With Metastatic Melanoma: Impact on Surgical Decision MakingClinical Nuclear Medicine, 2003
- Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patientsAnnals of Surgical Oncology, 2002
- Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Micrometastases of Primary Cutaneous Malignant MelanomaJournal of Clinical Oncology, 2001
- Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionineEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign VariantsRadioGraphics, 1999
- Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretationSeminars in Nuclear Medicine, 1996
- Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1995